Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis After Suspected Aspiration in ICU
NCT05079620Phase 4Terminated
- Sponsor
- UConn Health
- Start
- Nov 2021
- Primary completion
- Apr 2024
- Modality
- Reversible Covalent Inhibitors, Cyclic Peptides, Antimicrobial Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of ceftriaxone, amoxicillin + clavulanate, cefepime, vancomycin, levofloxacin in aspiration pneumonia, sponsored by UConn Health. Started Nov 2021; status: terminated.
02
Drugs
ceftriaxoneamoxicillin + clavulanatecefepimevancomycinlevofloxacin
03
Conditions
aspiration pneumonia
Beyond the preview
Go deeper on NCT05079620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05079620.